Avadel Pharmaceuticals PLC (AVDL) — Defensive Interval Ratio
Avadel Pharmaceuticals PLC (AVDL) has a Defensive Interval Ratio of 317 days as of September 2025. Defensive assets of $54.21 Million (cash $-, short-term investments $11.76 Million, receivables $42.44 Million) cover 317 days of daily cash needs of $171.20K/day. Check tangible net worth ratio of Avadel Pharmaceuticals PLC to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Avadel Pharmaceuticals PLC Defensive Interval Ratio (1996–2024)
This chart shows how Avadel Pharmaceuticals PLC's Defensive Interval Ratio has evolved across 29 annual periods from 1996 to 2024. As of September 2025, the ratio stands at 317 days, meaning defensive assets of $54.21 Million can fund 317 days of operations without new revenue. Also explore AVDL net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Avadel Pharmaceuticals PLC (1996–2024)
The table below presents the year-by-year Defensive Interval Ratio for Avadel Pharmaceuticals PLC from 1996 to 2024, covering 29 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Avadel Pharmaceuticals PLC stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 422 days | $56.50 Million | $133.79K/day | $- | $22.41 Million | ▼ -430 days |
| 2023 | 852 days | $86.05 Million | $100.97K/day | $- | $73.94 Million | ▲ +690 days |
| 2022 | 162 days | $24.77 Million | $152.86K/day | $- | $22.52 Million | ▼ -2237 days |
| 2021 | 2399 days | $138.05 Million | $57.53K/day | $- | $106.51 Million | ▼ -2153 days |
| 2020 | 4553 days | $188.46 Million | $41.39K/day | $- | $149.68 Million | ▲ +3880 days |
| 2019 | 673 days | $66.36 Million | $98.59K/day | $- | $54.38 Million | ▼ -321 days |
| 2018 | 994 days | $104.50 Million | $105.16K/day | $- | $90.59 Million | ▲ +596 days |
| 2017 | 398 days | $94.02 Million | $236.10K/day | $- | $77.51 Million | ▼ -378 days |
| 2016 | 777 days | $132.82 Million | $171.02K/day | $- | $114.98 Million | ▲ +124 days |
| 2015 | 653 days | $87.22 Million | $133.67K/day | $- | $79.74 Million | ▲ +334 days |
| 2014 | 318 days | $61.76 Million | $194.09K/day | $- | $53.07 Million | ▲ +126 days |
| 2013 | 193 days | $21.43 Million | $111.22K/day | $- | $401.00K | ▼ -305 days |
| 2012 | 498 days | $19.59 Million | $39.34K/day | $- | $6.41 Million | ▼ -107 days |
| 2011 | 605 days | $30.34 Million | $50.18K/day | $- | $21.04 Million | ▼ -46 days |
| 2010 | 650 days | $34.60 Million | $53.21K/day | $- | $23.16 Million | ▼ -236 days |
| 2009 | 886 days | $55.61 Million | $62.73K/day | $- | $35.35 Million | ▲ +357 days |
| 2008 | 529 days | $29.38 Million | $55.49K/day | $- | $10.06 Million | ▲ +136 days |
| 2007 | 393 days | $26.89 Million | $68.37K/day | $- | $14.75 Million | ▲ +52 days |
| 2006 | 341 days | $19.93 Million | $58.39K/day | $- | $10.94 Million | ▼ -910 days |
| 2005 | 1251 days | $85.34 Million | $68.21K/day | $- | $82.76 Million | ▼ -454 days |
| 2004 | 1705 days | $108.99 Million | $63.91K/day | $- | $100.78 Million | ▼ -680 days |
| 2003 | 2386 days | $116.78 Million | $48.95K/day | $- | $108.42 Million | ▲ +2191 days |
| 2002 | 194 days | $3.46 Million | $17.83K/day | $- | $- | ▼ -235 days |
| 2001 | 429 days | $7.60 Million | $17.70K/day | $- | $- | ▲ +271 days |
| 2000 | 158 days | $2.64 Million | $16.75K/day | $- | $- | ▼ -11 days |
| 1999 | 168 days | $1.61 Million | $9.58K/day | $- | $- | ▼ -100 days |
| 1998 | 268 days | $3.19 Million | $11.93K/day | $- | $- | ▼ -26 days |
| 1997 | 294 days | $3.30 Million | $11.23K/day | $- | $- | ▲ +218 days |
| 1996 | 76 days | $1.00 Million | $13.15K/day | $- | $- | — |